Pioglitazone for adults with high risk of developing type 2 diabetes mellitus

Li Cao, Haiyan Sun, Hongmei Wu, Qingguo Lü, Alexis M. Mckee

Research output: Contribution to journalArticlepeer-review

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects of pioglitazone for adults with high risk of developing type 2 diabetes, which includes impaired glucose tolerance (IGT), impaired fasting blood glucose (IFG) and glycosylated haemoglobin A1c (HbA1c) measurements 5.7% to 6.4%.

Original languageEnglish
Article numberCD011759
JournalCochrane Database of Systematic Reviews
Volume2015
Issue number6
DOIs
StatePublished - Jun 24 2015

Fingerprint

Dive into the research topics of 'Pioglitazone for adults with high risk of developing type 2 diabetes mellitus'. Together they form a unique fingerprint.

Cite this